Friday, November 28, 2014
Loading...





FDA approves Biogen's MS drug Plegridy

Biogen receives approval of treatment for multiple sclerosis patients
Posted on Aug. 15, 2014 at 12:00 a.m. | Updated on Aug. 15, 2014 at 7:27 p.m.

CAMBRIDGE, Mass. (AP) — Biogen Idec says that federal regulators have approved the specialty drugmaker’s new treatment for people with relapsing forms of multiple sclerosis.

The company said Friday that the Food and Drug Administration cleared the injectable drug, dubbed Plegridy, after reviewing results from a study that involved more than 1,500 people with the disease.

Multiple sclerosis is a disease of the immune system in which the body attacks the brain and spinal cord.

Its symptoms can come and go, often reappearing months later.

The European Commission recently approved Plegridy.

Biogen also markets the multiple sclerosis drugs Avonex and Tysabri.

Shares of Biogen Idec Inc. ended regular trading up $5.46, or 1.6 percent, to $342.47 on Friday.

The stock is up 22 percent this year.




Recommended for You


 Christmas trees sit covered in snow on the family-run Howell Tree Farm, Wednesday, Nov. 26, 2014, in Cumming, Iowa. After several tough years, the nation’s Christmas-tree growers are happy to see higher prices, but customers shouldn’t worry too much. (AP Photo/Charlie Neibergall)

Posted 9 minutes ago

Posted 29 minutes ago
 Lights twinkle in a mall in Canberra, Australia where David Richards has set a Guinness World Record by stringing up almost 1.2 million Christmas lights in the center of the national capital, Thursday, Nov. 27, 2014. Guinness World Records on Friday confirmed that the 120 kilometers (75 miles) of multicolored wire strung in the shape of three interconnected giant, wrapped Christmas gifts was the world’s largest image made of Light Emitting Diode, or LED, lights.  (AP Photo/AAP Image, Alan Porritt) AUSTRALIA OUT, NEW ZEALAND OUT, PAPUA NEW GUINEA OUT, SOUTH PACIFIC OUT, NO SALES

Posted 1 hour ago
Back to top ^